CXCR3 signalling partially contributes to the pathogenesis of neuropathic pain in male rodents

• DOI: 10.1111/joor.13262
• Publication Date: 2021-09-27T21:33:32Z
• Authors: Kai Li; Yong‐Hui Tan; Shi‐Yang Feng; Kai‐Yuan Fu
• Keywords: Male; Rats, Sprague-Dawley; 0301 basic medicine; Mice; 03 medical and health sciences; Receptors, CXCR3; Hyperalgesia; Animals; Neuralgia; Rodentia; Sciatic Nerve; Rats

AbstractBackgroundCurrently, there is a lack of effective therapy for chronic pain. Increasing evidence has shown that chemokines and their correlative receptors involved in the neuron–glial cell cross‐talk could contribute to the pathogenesis of neuropathic pain. Our previous studies suggested that CXCR3 expression was elevated in the spinal dorsal horn after nerve injury.ObjectivesIn this study, we aimed to explore the role of CXCR3 signalling in chronic pain modulation.MethodsReverse transcription quantitative PCR and Western blotting were used to measure the expression of CXCR3 and its ligands in the spinal cord following chronic constriction injury (CCI) of the sciatic nerve. Cxcr3 ‐knockout mice were used to observe the effect of the receptor on pain‐related behaviour and microglial activation. Immunohistochemistry was used to investigate the expression of two activation markers for spinal microglia, Iba‐1 and phosphorylated‐p38 (p‐p38) in these mice.ResultsThe expression of CXCR3 and its ligand CXCL11 was upregulated in the lumbar dorsal horn of the spinal cord in CCI models. In Cxcr3 ‐knockout mice, CCI‐induced tactile allodynia and thermal hyperalgesia were observed to be alleviated during the early stage of pain processing. Meanwhile, the expression of the glial activation markers, namely, Iba‐1 and p‐p38, was decreased.ConclusionOur results demonstrate that CXCR3 could be a key modulator involved in pain modulation of the spinal cord; therefore, CXCR3‐related signalling pathways could be potential targets for the treatment of intractable pathological pain.